HYDMA_HYDVU
ID HYDMA_HYDVU Reviewed; 84 AA.
AC B3RFR8;
DT 15-JUN-2010, integrated into UniProtKB/Swiss-Prot.
DT 02-SEP-2008, sequence version 1.
DT 03-AUG-2022, entry version 29.
DE RecName: Full=Hydramacin-1;
DE Short=Hm-1;
DE Flags: Precursor;
OS Hydra vulgaris (Hydra) (Hydra attenuata).
OC Eukaryota; Metazoa; Cnidaria; Hydrozoa; Hydroidolina; Anthoathecata;
OC Aplanulata; Hydridae; Hydra.
OX NCBI_TaxID=6087;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 39-50, FUNCTION,
RP SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION, PYROGLUTAMATE
RP FORMATION AT GLN-25, AND MASS SPECTROMETRY.
RX PubMed=19013190; DOI=10.1016/j.dci.2008.10.004;
RA Bosch T.C.G., Augustin R., Anton-Erxleben F., Fraune S., Hemmrich G.,
RA Zill H., Rosenstiel P., Jacobs G., Schreiber S., Leippe M., Stanisak M.,
RA Groetzinger J., Jung S., Podschun R., Bartels J., Harder J.,
RA Schroeder J.-M.;
RT "Uncovering the evolutionary history of innate immunity: the simple
RT metazoan Hydra uses epithelial cells for host defence.";
RL Dev. Comp. Immunol. 33:559-569(2009).
RN [2]
RP STRUCTURE BY NMR OF 25-84, DISULFIDE BONDS, FUNCTION, AND SUBCELLULAR
RP LOCATION.
RX PubMed=19019828; DOI=10.1074/jbc.m804713200;
RA Jung S., Dingley A.J., Augustin R., Anton-Erxleben F., Stanisak M.,
RA Gelhaus C., Gutsmann T., Hammer M.U., Podschun R., Bonvin A.M.J.J.,
RA Leippe M., Bosch T.C.G., Grotzinger J.;
RT "Hydramacin-1, structure and antibacterial activity of a protein from the
RT basal metazoan Hydra.";
RL J. Biol. Chem. 284:1896-1905(2009).
CC -!- FUNCTION: Cationic antimicrobial peptide potently active against Gram-
CC positive and Gram-negative bacteria including multi-resistant human
CC pathogenic strains. Is not active against the Gram-positive Coccus
CC species, Gram-negative non-fermentation species and against the fungus
CC C.albicans. It leads to aggregation of bacteria as an initial step of
CC its bactericidal mechanism. Aggregated cells are connected via
CC electron-dense contacts and adopt a thorn apple-like morphology.
CC Hydramycin contains a belt of positively charged residues that separate
CC two hydrophobic areas. This structure may explain the observed
CC aggregation of bacteria, since each of these areas can immerse into the
CC outer leaflets of the membranes of two individual bacteria. Is able to
CC permeabilize membranes of viable bacteria at low and neutral pH values,
CC but no pore-forming activity is not detected.
CC {ECO:0000269|PubMed:19013190, ECO:0000269|PubMed:19019828}.
CC -!- SUBCELLULAR LOCATION: Secreted. Target cell membrane.
CC -!- TISSUE SPECIFICITY: Expressed in the endodermal epithelium.
CC {ECO:0000269|PubMed:19013190}.
CC -!- INDUCTION: By bacterial lipopolysaccharides (LPS).
CC {ECO:0000269|PubMed:19013190}.
CC -!- MASS SPECTROMETRY: Mass=6994; Method=Electrospray;
CC Evidence={ECO:0000269|PubMed:19013190};
CC -!- SIMILARITY: Belongs to the macin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; DQ449931; ABE26989.1; -; mRNA.
DR EMBL; CX833582; -; NOT_ANNOTATED_CDS; mRNA.
DR PDB; 2K35; NMR; -; A=25-84.
DR PDBsum; 2K35; -.
DR AlphaFoldDB; B3RFR8; -.
DR BMRB; B3RFR8; -.
DR SMR; B3RFR8; -.
DR EvolutionaryTrace; B3RFR8; -.
DR Proteomes; UP000694840; Unplaced.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR Gene3D; 3.30.30.100; -; 1.
DR InterPro; IPR029230; Macin.
DR InterPro; IPR038456; Macin_sf.
DR Pfam; PF14865; Macin; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Antibiotic; Antimicrobial; Direct protein sequencing;
KW Disulfide bond; Immunity; Innate immunity; Membrane;
KW Pyrrolidone carboxylic acid; Reference proteome; Secreted; Signal;
KW Target cell membrane; Target membrane.
FT SIGNAL 1..24
FT CHAIN 25..84
FT /note="Hydramacin-1"
FT /id="PRO_0000394509"
FT MOD_RES 25
FT /note="Pyrrolidone carboxylic acid"
FT /evidence="ECO:0000269|PubMed:19013190"
FT DISULFID 29..72
FT /evidence="ECO:0000269|PubMed:19019828"
FT DISULFID 36..65
FT /evidence="ECO:0000269|PubMed:19019828"
FT DISULFID 51..81
FT /evidence="ECO:0000269|PubMed:19019828"
FT DISULFID 55..83
FT /evidence="ECO:0000269|PubMed:19019828"
FT STRAND 30..32
FT /evidence="ECO:0007829|PDB:2K35"
FT HELIX 33..38
FT /evidence="ECO:0007829|PDB:2K35"
FT TURN 41..44
FT /evidence="ECO:0007829|PDB:2K35"
FT HELIX 50..56
FT /evidence="ECO:0007829|PDB:2K35"
FT TURN 57..59
FT /evidence="ECO:0007829|PDB:2K35"
FT STRAND 63..67
FT /evidence="ECO:0007829|PDB:2K35"
FT HELIX 69..71
FT /evidence="ECO:0007829|PDB:2K35"
FT TURN 75..77
FT /evidence="ECO:0007829|PDB:2K35"
FT STRAND 79..83
FT /evidence="ECO:0007829|PDB:2K35"
SQ SEQUENCE 84 AA; 9651 MW; 414E74FA879D791A CRC64;
MRTVVFFILV SIFLVALKPT GTQAQIVDCW ETWSRCTKWS QGGTGTLWKS CNDRCKELGR
KRGQCEEKPS RCPLSKKAWT CICY